Effective November 1, 2020, Douglas Karas, a board director of Nascent Biotech for the past four years, joins the Company's core team as Chief Operating Officer and head of Corporate Development and Dr. Ivan Babic, who has been involved with the Company since 2014, joins officially as Consulting Director of Research.
Sean Carrick, CEO of Nascent Biotech, commented, "As the Company moves into its clinical stage, personnel additions are necessary to support the transition of Nascent Biotech into a key player in the oncology arena by matching the caliber and promise of our intellectual property with an experienced, talented, and credible team."